| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/14/2005 | CN1668323A Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 09/14/2005 | CN1668316A Anti-spasmodic comprising xenon |
| 09/14/2005 | CN1668293A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 09/14/2005 | CN1668212A Compositions comprising lactoferrin |
| 09/14/2005 | CN1666778A Anti-oxidation, anti-senium oyster product and its preparation method |
| 09/14/2005 | CN1666765A Natural antioxidant with human immunity-enhancing and virus-preventing functions |
| 09/14/2005 | CN1666741A Stable naloxone freeze dried powder injection and preparation technology thereof |
| 09/14/2005 | CN1218960C Ginkgo protein GAPIIa and its preparing method and use |
| 09/13/2005 | US6943182 Cyclopentabenzofuran derivatives and their use |
| 09/09/2005 | WO2005082860A1 Tetracyclines and their use as calpain inhibitors |
| 09/09/2005 | CA2554908A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
| 09/09/2005 | CA2554823A1 Nk-1 receptor antagonists to improve anesthesia recovery |
| 09/07/2005 | EP1307438B1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 09/07/2005 | EP1294369B1 NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE |
| 09/07/2005 | EP1221959B1 Use of parvoviruses for improving the general condition of tumour patients or patients having chronic or consumptive diseases |
| 09/07/2005 | CN1665764A An hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
| 09/07/2005 | CN1665537A Use of CETP inhibitors and optionally HMG COA reductable inhibitors and/or antihypertensive agents |
| 09/07/2005 | CN1663606A Medicine for treating radiation diseases |
| 09/07/2005 | CN1663563A Compound troxerutin and piracetam formulation and application thereof |
| 09/07/2005 | CN1217939C Compound of phycocyania of blue-green algae, its preparing method and usage |
| 09/07/2005 | CN1217927C Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 09/07/2005 | CN1217657C Method of improving survival of patients |
| 09/06/2005 | US6939559 Pharmaceutical composition for application to mucosa |
| 09/01/2005 | WO2005079506A2 Systemic immune activation method using nucleic acid-lipid complexes |
| 09/01/2005 | US20050192308 N-but-E-enyl norbuprenorphine and methods of use |
| 09/01/2005 | US20050191374 Soluble composition containing sporopollenin and the use thereof |
| 09/01/2005 | US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 09/01/2005 | US20050191289 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 09/01/2005 | US20050191268 Polyphenol-and protein-containing extracts of winemaking residues, and methods of using the same |
| 09/01/2005 | DE19964224B4 Pharmazeutische Mittel enthaltend Calcium-Komplex von Pharmaceutical preparations containing calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) und dessen Salze sowie Verfahren zur Herstellung der Mittel tetra hydrogen (MS-325) and salts thereof as well as methods for preparing the compositions |
| 08/31/2005 | EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 08/31/2005 | EP1267881B1 USE OF MnTBAP FOR TREATING HEPATOCELLULAR INSUFFICIENCIES |
| 08/31/2005 | EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 08/31/2005 | EP1058542B1 Method for producing encased spherical granular grains comprising prostane derivatives |
| 08/31/2005 | EP1003497B1 Il-8 receptor antagonists |
| 08/31/2005 | CN1662511A Pharmaceutical salts of reboxetine |
| 08/31/2005 | CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 08/31/2005 | CN1662222A Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 08/31/2005 | CN1662152A Nutritious compositions for detoxification and cancer prevention |
| 08/31/2005 | CN1660224A High preformance oxidation resistant combination extracted from plants |
| 08/31/2005 | CN1660139A Method for preparing oral medication by using extractive from oyster alone |
| 08/31/2005 | CN1660117A Application of diltiazem of hydrochloric acid in preparing antidote |
| 08/31/2005 | CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/31/2005 | CN1660058A Application of zinc taurine in preparing medication for anti anoxia |
| 08/30/2005 | US6936633 Pyrrolidinone derivatives |
| 08/30/2005 | US6936260 For tubercolosis, antigen is inactivated Mycobacterium tuberculosis bacteria, and the adjuvant is a mixture of a fatty acid and a monoglyceride; elicits lowest tumor necrosis factor alpha (TNF-alpha); dosage forms such as nose drops |
| 08/30/2005 | US6936250 Polysaccharide encapsualted antigen |
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
| 08/25/2005 | US20050187197 Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof |
| 08/25/2005 | CA2556404A1 Nitrogenous fused heteroaromatic ring derivative |
| 08/24/2005 | EP1566182A1 Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure |
| 08/24/2005 | EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases |
| 08/24/2005 | EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 08/24/2005 | CN1658885A Hormone replacement therapy |
| 08/24/2005 | CN1657090A Extract of prinsepia wood and its bioactivity function |
| 08/24/2005 | CN1657048A Laminaran granule and its preparation technology |
| 08/24/2005 | CN1215849C Method for preparing baicalin liquid |
| 08/23/2005 | CA2223469C Use of dopamine receptor antagonists in palliative tumour therapy |
| 08/23/2005 | CA2111571C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 08/18/2005 | WO2005074909A1 Combination drug |
| 08/18/2005 | US20050182141 drug abuse, drug addiction; reduce cravings for food or addictive substance such as cocaine, amphetamine, nicotine, opiates, tobacco, alcohol or ecstasy; ketone or hydroxy aryl-cycloalkyl sulfides or S-oxides thereof e.g. 1-(1-(3,4-dichlorophenyl)cyclobutyl)-2-(2-(dimethylamino)ethylthio)ethanone |
| 08/18/2005 | US20050182064 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 08/18/2005 | US20050181054 comprising a water-insoluble and/or water-low soluble substance, a medicament, and an aqueous medium, and having an osmotic pressure of less than 290 mOsm; efficient penetration and high permeability blood at the mucosa |
| 08/18/2005 | US20050181046 Tamper-resistant oral opioid agonist formulations |
| 08/18/2005 | US20050180963 Probiotic propionibacterium |
| 08/18/2005 | CA2555316A1 Combined pharmaceutical composition |
| 08/17/2005 | EP1562613A1 Nadh/nadph-containing compound |
| 08/17/2005 | EP1562579A1 Therapeutic delivery of carbon monoxide |
| 08/17/2005 | EP1236724B1 Neutralizing agent for toxin of microorganism belonging to the genus clostridium |
| 08/17/2005 | CN1656098A Fused bicyclic pyrimidine derivatives |
| 08/17/2005 | CN1655761A Modified release pharmaceutical formulation |
| 08/17/2005 | CN1654473A 重组幽门螺杆菌过氧化氢酶 Recombinant H. pylori catalase |
| 08/17/2005 | CN1215052C Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | US6929012 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176811 Vitamin combination for providing protection during the chemotherapy and/or radio-therapy of malignant tumours |
| 08/11/2005 | US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/11/2005 | US20050175555 2,4,6,8,10,12,14-hexadecaheptaenol in cyclodextrins; antitumor , antiinflammatory, antiaging, antiprolifrative agent, antioxident; activation of free radical production, cardiovascular disorders, atherosclerosis; cosmetic and pharmaceutical use |
| 08/11/2005 | CA2851972A1 Methods for reducing oxidative damage |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 08/10/2005 | EP1324760A4 Creatine ester pronutrient compounds and formulations |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652808A Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 08/10/2005 | CN1652769A Phosphate prodrugs of fluorooxindoles |
| 08/10/2005 | CN1651362A One and two step ultracritical fluid extraction of carotene, VE and other trace element concentration |
| 08/10/2005 | CN1650972A Glow release micro pill containing gingko leaf extract and its preparation method |
| 08/10/2005 | CN1650908A Method of extracting total flavone product from halenalin plant full flower |
| 08/10/2005 | CN1650891A Medicinal composition posssessing synergistic action |
| 08/10/2005 | CN1650877A Slow release preparation of diammonium glycyrrhizate |